Graft-versus-host disease (GvHD) is a serious complication of allogeneic hematopoietic cell
transplantation causing significant morbidity and mortality. Corticosteroids are the …

Extracorporeal photopheresis (ECP) has been widely used as a second line therapy for
treatment of cGVHD with recognized efficacy as a steroid sparing intervention (2, 3). It is a …

Acute and chronic graft-versus-host disease (GVHD) continue to be major limitations to
successful hematopoietic stem cell transplantation. A variety of different immunosuppressive …

Background Extracorporeal photopheresis (ECP) is considered a valid second-line
treatment for acute and chronic graft versus host disease (GVHD). Methods Ninety-four …

Extracorporeal photopheresis (ECP) is an established therapy for the treatment of graft‐
versus‐host‐disease (GVHD) following an allogeneic stem cell transplant. We performed a …

Extracorporeal photopheresis (ECP) is an accepted treatment for chronic graft-versus-host
disease (cGVHD); however, the mechanism of action is unclear. We conducted a …

Objectives Chronic graft versus host disease (GVHD) is one of the major obstacles to
achieve success in allogeneic hematopoietic stem cell transplantation (allo-HSCT) …

Background Extracorporeal photopheresis (ECP) has been shown as active therapy for graft‐
versus‐host disease (GVHD). Study Design and Methods The aim was to ascertain the role …

Introduction Steroid-refractory graft-versus-host disease (GVHD) remains a challenging
therapeutic problem after allogeneic hematopoietic stem cell transplantation (HSCT). The …

BACKGROUND Extracorporeal photopheresis (ECP) is a recognized second‐line treatment
for steroid‐refractory chronic graft‐versus‐host disease (cGVHD). Treatment course is …